Answers are grounded in this paper and cite their sources.
In patients with early rheumatoid arthritis who had a remission while receiving full-dose etanercept-plus-methotrexate therapy, continuing combination therapy at a reduced dose resulted in better disease control than switching to methotrexate alone or placebo, but no significant difference was observed in radiographic progression. (Funded by Pfizer; ClinicalTrials.gov number, NCT00913458.).
No takes yet. Share an insight, caveat, or question.
Emery et al. (2014) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: